BioSpace News Archive

Median Technologies (Paris:ALMDT), The Imaging Phenomics Company® announced today that it had received the disbursement of €15 million, corresponding to the first tranche of the loan granted by the European Investment Bank (EIB).

Fresenius Kabi USA, LLC is voluntarily recalling Ketorolac Tromethamine Injection, USP, 60 mg/2 mL, 2 mL fill in a 2 mL amber vial to the user level due to the presence of particulate matter.

Braid Health and Carbon Health Also Launch Initiative to Compile and Share COVID-19 Clinical Data with Frontline Healthcare Providers and Data Scientists

As healthcare professionals and first responders have come under increasing strain due to the COVID-19 crisis, Novolex has retooled its manufacturing capabilities and repurposed its supply chains to develop products to protect them.

Sharecare, the digital health company that helps people manage all their health in one place, today announced the launch of an interactive COVID-19 screener – developed in partnership with IPsoft and NTT DATA – to provide the general public with a helpful way to anonymously self-screen for the novel coronavirus

Today The Essentials Group, a business affiliate of The Center for Health Affairs, and Ascend Innovations announced a newly formed business partnership designed for strategic collaboration, innovation and delivery of services and solutions that will impact healthcare and community health across Ohio and beyond.

BeiGene, Ltd. announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted a supplemental new drug application of BeiGene’s anti-PD-1 antibody tislelizumab in combination with two chemotherapy regimens for first-line treatment of patients with advanced squamous non-small cell lung cancer.

Calithera Biosciences, Inc. announced the closing of its previously announced public offering of 5,750,000 shares of common stock, including 750,000 shares sold pursuant to the underwriter’s exercise in full of its option to purchase additional shares.

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, announced the appointment of Scott Whitcup, M.D. to the Company’s Board of Directors.

Novan, Inc. announced that it has engaged H.C. Wainwright & Co., LLC to assist the Company in exploring and evaluating a range of strategic and financial alternatives, intended to maximize shareholder value.